{
  "subset": "contraindication",
  "disease": "Familial tumour syndromes of the central and peripheral nervous system",
  "relation": "contraindication",
  "gold_drugs": [
    "busulfan",
    "cyproheptadine",
    "dasatinib",
    "donepezil",
    "doxorubicin hcl liposome",
    "etoposide",
    "ifosfamide",
    "megestrol",
    "melphalan",
    "mesna",
    "polyvinylpyrrolidone-sodium hyaluronate gel",
    "thiotepa"
  ],
  "seeds_initial": [
    "Vemurafenib",
    "Dabrafenib",
    "Trametinib",
    "Sunitinib",
    "Sorafenib",
    "Everolimus",
    "Cyclophosphamide",
    "Irinotecan",
    "Etoposide",
    "Carboplatin",
    "Temozolomide",
    "Bevacizumab"
  ],
  "seed_history": [
    [
      "Vemurafenib",
      "Dabrafenib",
      "Trametinib",
      "Sunitinib",
      "Sorafenib",
      "Everolimus",
      "Cyclophosphamide",
      "Irinotecan",
      "Etoposide",
      "Carboplatin",
      "Temozolomide",
      "Bevacizumab"
    ],
    [
      "Cisplatin",
      "Vincristine",
      "Carboplatin",
      "Doxorubicin",
      "Methotrexate",
      "Cyclophosphamide",
      "Ifosfamide",
      "Tamoxifen",
      "Alimta",
      "Thalidomide",
      "Procarbazine",
      "Trametinib"
    ],
    [
      "Vincristine",
      "Cisplatin",
      "Carmustine",
      "Temozolomide",
      "Lomustine",
      "Doxorubicin",
      "Etoposide",
      "Thiotepa",
      "Cyclophosphamide",
      "Nitrosourea",
      "Methotrexate",
      "Ifosfamide"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H1_round3",
        "key_assumptions": [
          "已知作用靶点为微管",
          "需考虑对称性感觉异常风险"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_cisplatin",
          "name": "Cisplatin"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H2_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "影响神经组织的潜在风险需纳入考虑"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_carmustine",
          "name": "Carmustine"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H3_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估对中枢神经系统的毒性作用"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H4_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估可能降低神经元再生能力"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_lomustine",
          "name": "Lomustine"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H5_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估其对神经细胞的毒性影响"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_doxorubicin",
          "name": "Doxorubicin"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H6_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需警惕心脏毒性及其对神经的潜在影响"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H7_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需注意可能导致神经细胞变化的风险"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_thiotepa",
          "name": "Thiotepa"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H8_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估神经系统的潜在毒性"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H9_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需警惕对神经系统的潜在负面影响"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_nitrosourea",
          "name": "Nitrosourea"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H10_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估其潜在神经毒性"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H11_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需考虑对神经系统的潜在损伤"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_ifosfamide",
          "name": "Ifosfamide"
        },
        "score": 0.39,
        "graph_snapshot_ref": "GE_H12_round3",
        "key_assumptions": [
          "已知作用靶点为DNA",
          "需评估对神经系统的副作用风险"
        ],
        "caveats": [
          "安全性尚需进一步确认，特别是在家庭肿瘤综合症患者中可能存在的风险"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [],
      "remaining_gaps": [
        "所有候选的安全性风险未得到充分证据支持，特别是在家庭肿瘤综合症患者中"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": [
        "需关注药物对家庭肿瘤综合症患者特有风险的评估以及更多数据的收集"
      ]
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Familial tumour syndromes of the central and peripheral nervous system'. Return only names.\n\n# Heuristics:\n- When 潜在的神经毒性: then 药物类别与安全性需著重评估，包括可能的中枢与外周神经影响"
}